检索结果-南通市图书馆

2.15-2.16年四川省高血压患者接受基层健康管理服务后血压控制效果分析

在线全文

学校读者我要写书评

暂无评论

预防医学情报杂志 2018年第4期34卷 409-413页

作者：关旭静唐雪峰吴先萍金必辉王梅引梅榕蒋秀文桑振修四川省疾病预防控制中心成都610041 四川省妇幼保健院保健部成都610041 四川省精神卫生中心成都610041

目的分析2.15-2.16年四川省基本公共卫生服务项目中高血压患者接受健康管理服务后血压控制情况,为科学评判控制效果提供依据。方法采取多阶段分层随机抽样方法,在全省分别抽取2.个县(区)的42.乡镇卫生院(社区卫生服务中心)开展调查,在... 详细信息

目的分析2.15-2.16年四川省基本公共卫生服务项目中高血压患者接受健康管理服务后血压控制情况,为科学评判控制效果提供依据。方法采取多阶段分层随机抽样方法,在全省分别抽取2.个县(区)的42.乡镇卫生院(社区卫生服务中心)开展调查,在每个机构等距抽取高血压患者健康档案各10份开展电话调查,核查档案表单、个人信息、体检记录、随访信息等,根据国家基本公共卫生服务规范设定条件判断档案信息准确性和服务规范性,记录最后一次随访时的血压,并邀请患者到机构现场测量血压,对血压控制情况进行分析。结果 2.15-2.16年,四川省高血压患者档案记录血压控制率为84.13%,现场测量血压控制率为41.67%,差异有统计学意义(χ~2.12.889,P2.2..61,P2.0.54,P=0.46)。不同满意度及不同年度的血压控制率差异均无统计学意义。结论四川省高血压患者健康管理服务取得较好效果,需进一步探索控制效果评判机制。

关键词：高血压效果健康管理

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia(2.2. Edition)

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2022年第5期9卷 515-533页

作者： Xian-Tao Zeng Ying-Hui Jin Tong-Zu Liu Fang-Ming Chen De-Gang Ding Meng Fu Xin-Quan Gu Bang-Min Han Xing Huang Zhi Hou Wan-Li Hu Xin-Li Kang Gong-Hui Li Jian-Xing Li Pei-Jun Li Chao-Zhao Liang Xiu-Heng Liu Zhi-Yu Liu Chun-Xiao Liu Jiu-Min Liu Guang-Heng Luo Yi Luo Wei-Jun Qin Jian-Hong Qiu Jian-Xin Qiu Xue-Jun Shang Ben-Kang Shi Fa Sun Guo-Xiang Tian Ye Tian Feng Wang Feng Wang Yin-Huai Wang Yu-Jie Wang Zhi-Ping Wang Zhong Wang Qiang Wei Min-Hui Xiao Wan-Hai Xu Fa-Xian Yi Chao-Yang Zhu Qian-Yuan Zhuang Li-Qun Zhou Xiao-Feng Zou Nian-Zeng Xing Da-Lin He Xing-Huan Wang 无 department of Urology Institute of UrologyZhongnan Hospital of Wuhan UniversityWuhan430071China Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan430071China department of Urology Tianjin Third Central Hospital Affiliated To Nankai UniversityTianjin300170China department of Urology Henan Provincial People’s HospitalZhengzhou University People’s HospitalZhengzhou450003China department of Urology Beijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijing102218China department of Urology China-Japan Union Hospital of Jilin UniversityChangchun130033China department of Urology Shanghai General HospitalShanghai Jiao Tong University School of MedicineShanghai200080China department of Urology Qinghai University Affiliated HospitalXi’ning810012China department of Urology People’s Hospital of Hainan ProvinceHainan Affiliated Hospital of Hainan Medical University HaikouHaikou570311China department of Urology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou310016China department of Urology General Hospital of Ningxia Medical UniversityYinchuan750003China department of Urology The First Affiliated Hospital of Anhui Medical UniversityHefei230022China department of Urology Renmin Hospital of Wuhan UniversityWuhan430060China department of Urology The Second Hospital of Dalian Medical UniversityDalian116023LiaoningChina department of Urology Zhujiang Hospital of Southern Medical UniversityGuangzhou510282China department of Urology Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou510080China department of Urology Surgery Guizhou Province People’s HospitalGuiyang550002China department of Urology Xijing Hospital of Air Force Military Medical UniversityXi’an710032China department of Urology The 980St Hospital of the PLA Joint Logistics Support Force(Bethune International Peace Hospital of PLA)Shijiazhuang050082China department of Urology

Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2.18, we issued the guideline “2.18 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 2. carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different

关键词： Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Recommendation Treatment Guideline

上胸段交感神经阻滞疗法中国专家共识(2.2.版)

在线全文

学校读者我要写书评

暂无评论

中华疼痛学杂志 2023年第6期19卷 885-896页

作者：上胸段交感神经阻滞疗法中国专家共识编写专家组过建国杜鑫丹任飞宋涛薛朝霞杨立强金晓红林慧丹陆丽娟吴大胜刘慧姚明唐靖黄冰冯智英不详浙江大学医学院附属第一医院疼痛科杭州市310001 浙江省中西医结合医院疼痛科杭州市310003 中南大学湘雅医院麻醉科长沙市410008 中国医科大学附属第一医院疼痛科沈阳市110001 山西医科大学第一医院疼痛科太原市030001 首都医科大学宣武医院疼痛科北京100053 苏州大学附属第一医院麻醉科苏州市215006 宁波市第一医院疼痛科浙江省宁波市315000 南京大学医学院附属鼓楼医院疼痛科南京市210008 吉林省人民医院疼痛科长春市130021 四川大学华西医院疼痛科成都市610041 浙江省嘉兴市第一医院疼痛科浙江省嘉兴市314000 广东医科大学附属医院疼痛科广东省湛江市524001

经皮穿刺上胸段交感神经阻滞被广泛用于治疗多汗症、上肢和胸部缺血性疼痛、复杂性区域疼痛综合征等。目前国内临床应用日趋增加和普及,为进一步规范该技术,推动临床合理应用,《中华疼痛学杂志》编委会组织国内相关专家组成上胸段交感... 详细信息

经皮穿刺上胸段交感神经阻滞被广泛用于治疗多汗症、上肢和胸部缺血性疼痛、复杂性区域疼痛综合征等。目前国内临床应用日趋增加和普及,为进一步规范该技术,推动临床合理应用,《中华疼痛学杂志》编委会组织国内相关专家组成上胸段交感神经阻滞疼痛科专家共识编写专家组,参考国内外临床研究,深入探讨该技术临床应用的适应证、禁忌证、操作流程和并发症防治等问题,并形成本专家共识,予以发布。

关键词：交感神经系统胸部神经传导阻滞射频疗法专家共识

哮喘治疗依从性与肺功能和控制水平的相关性分析

在线全文

学校读者我要写书评

暂无评论

中国呼吸与危重监护杂志 2022年第11期21卷 761-767页

作者：王文雅林江涛刘春涛唐华平霍建民顾玉海刘荣玉陈萍袁雅冬杨晓红许建英孙德俊李娜嘉姜淑娟陈一强王长征杨岚刘晓菊杨冬张伟陈卓昌林其昌周建英周新胡成平蒋萍周玮张捷蔡绍曦邱晨黄茂黄奕江刘辉国中国哮喘研究协作组中日友好医院呼吸与危重症医学科国家呼吸疾病临床研究中心北京100029 四川大学华西医院呼吸与危重症医学科四川成都610041 青岛市立医院呼吸与危重症医学科山东青岛266071 哈尔滨医科大学第一附属医院呼吸科黑龙江哈尔滨150001 青海省人民医院呼吸科青海西宁810007 安徽医科大学第一附属医院呼吸与危重症医学科安徽合肥230022 北部战区总医院呼吸科辽宁沈阳110016 河北医科大学第二附属医院呼吸科河北石家庄050004 新疆维吾尔自治区人民医院呼吸与危重症医学科新疆乌鲁木齐830001 山西白求恩医院呼吸与危重症医学科山西太原030032 内蒙古人民医院呼吸与危重症医学科内蒙古呼和浩特010017 大庆油田总医院呼吸科黑龙江大庆163311 山东省人民医院呼吸与危重症医学科山东济南251411 广西医科大学第一附属医院呼吸内科广西南宁530021 陆军医科大学新桥医院呼吸内科重庆410037 西安交通大学附属第一医院呼吸与危重症医学科陕西西安710061 兰州大学第一医院老年呼吸科甘肃兰州730000 复旦大学附属中山医院呼吸内科上海200032 南昌大学第一附属医院呼吸内科江西南昌330006 河南省人民医院呼吸内科河南郑州450003 福建医科大学第一附属医院呼吸内科福建福州350005 浙江大学医学院附属第一医院呼吸内科浙江杭州310003 上海交通大学医学院附属上海市第一人民医院呼吸内科上海200080 中南大学湘雅医院呼吸与危重症医学科湖南长沙410008 天津市第一中心医院呼吸内科天津300192 宁夏医科大学总医院呼吸与危重症医学科宁夏银川750003 吉林大学第二医院呼吸与危重症医学科吉林长春130041 南方科技大学附属南方医院呼吸与危重症医学科广东广州510515 暨南大学第二临床医学院深圳市人民医院呼吸与危重症医学科广东深圳518020 南京医科大学附属第一医院呼吸与危重症医学科江苏南京211103 海南省人民医院呼吸与危重症医学科海南海口570031 华中科技大学同济医学院附属同济医院呼吸内科湖北武汉430030 不详

目的分析未控制的哮喘患者药物治疗依从性与肺功能、气道炎症水平、哮喘控制水平以及患者生活质量之间的关系,为改善患者依从性和提高哮喘控制水平提供依据。方法以我国内地2.个省市32.三甲医院未达到哮喘控制且依从性差的哮喘患者... 详细信息

目的分析未控制的哮喘患者药物治疗依从性与肺功能、气道炎症水平、哮喘控制水平以及患者生活质量之间的关系,为改善患者依从性和提高哮喘控制水平提供依据。方法以我国内地2.个省市32.三甲医院未达到哮喘控制且依从性差的哮喘患者作为研究对象,通过问卷调查的方式收集患者一般资料,所有患者均行肺功能、气道炎症水平检测,分析我国成人哮喘患者治疗依从性。结果调查共计92.例患者,调查问卷回收率100%。哮喘疾病认知相关问题回答完全正确者占2.3例(2..33%),哮喘疾病认知相关问题不能完全回答正确者占680例(73.67%)。哮喘患者治疗依从性与肺功能指标呈正相关,与呼出气一氧化氮呈明显负相关。治疗依从性高的哮喘患者,其哮喘控制水平和生活质量更高。哮喘患者治疗依从性不佳将会导致肺功能下降和气道炎症水平升高,使哮喘控制水平以及生活质量下降。结论哮喘治疗依从性与肺功能及气道炎症水平、哮喘控制水平和生活质量相关。

关键词：支气管哮喘治疗依从性哮喘控制生活质量肺功能

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2020年第3期7卷 249-282页

作者： Ying-Hui Jin Qing-Yuan Zhan Zhi-Yong Peng Xue-Qun Ren Xun-Tao Yin Lin Cai Yu-Feng Yuan Ji-Rong Yue Xiao-Chun Zhang Qi-Wen Yang Jianguang Ji Jian Xia Yi-Rong Li Fu-Xiang Zhou Ya-Dong Gao Zhui Yu Feng Xu Ming-Li Tu Li-Ming Tan Min Yang Fang Chen Xiao-Ju Zhang Mei Zeng Yu Zhu Xin-Can Liu Jian Yang Dong-Chi Zhao Yu-Feng Ding Ning Hou Fu-Bing Wang Hao Chen Yong-Gang Zhang Wei Li Wen Chen Yue-Xian Shi Xiu-Zhi Yang Xue-Jun Wang Yan-Jun Zhong Ming-Juan Zhao Bing-Hui Li Lin-Lu Ma Hao Zi Na Wang Yun-Yun Wang Shao-Fu Yu Lu-Yao Li Qiao Huang Hong Weng Xiang-Ying Ren Li-Sha Luo Man-Ru Fan Di Huang Hong-Yang Xue Lin-Xin Yu Jin-Ping Gao Tong Deng Xian-Tao Zeng Hong-Jun Li Zhen-Shun Cheng Xiao-Mei Yao Xing-Huan Wang Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Respiratory Diseases China-Japan Friendship HospitalBeijing 100029China department of Pulmonary and Critical Care Medicine China-Japan Friendship HospitalBeijing 10029China Leishenshan Hospital in Wuhan Wuhan 430200China department of Critical Care Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based Medicine and Knowledge Translation Henan UniversityKaifeng 475000HenanChina department of Medical Imaging Guizhou Provincial People’s HospitalGuiyang 550002China departments of Orthopedics Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Clinical Laboratory Peking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care Research Lund University and Region Skåne25002 MalmöSweden Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 403371China department of Allergology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan UniversityWuhan 43071China department of Critical Care Medicine Renmin Hospital of Wuhan UniversityWuhan 430060China department of Emergency Medicine and Chest Pain Center Qilu Hospital of Shandong UniversityJinan 250002China department of Respiratory and Critical Care Medicine Suizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina department of Clinic Pharmacy Second People’s Hospital of Huaihua Ci

The novel severe acute respiratory syndrome coronavirus 2.SARS-CoV-2.is the cause of a rapidly spreading illness,coronavirus disease 2.19(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issued"A rapid advice guideline for the diagnosis and treatment of 2.19 novel coronavirus(2.19-nCoV)infected pneumonia(standard version)";now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 2. questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34 *** them,6 were strong recommendations for,14 were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese Medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung

关键词： COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline

在线全文

学校读者我要写书评

暂无评论

膀胱肿瘤经尿道等离子电切术临床路径释义

医学新知 2022年第2期32卷 81-89页

作者：阎思宇黄兴陈征杨璐贾招辉彭谋任选义熊晶李晓东徐晓峰王永博李绪辉郑航王婷靳英辉訾豪刘同族曾宪涛贺大林王行环中国研究型医院学会泌尿外科学专业委员会中国医疗保健国际交流促进会循证医学分会国家重点研发计划微创等离子手术体系研发和产业化项目组武汉大学中南医院循证与转化医学中心武汉430071 武汉大学中南医院泌尿外科武汉430071 暨南大学附属第一医院泌尿外科广州510630 四川大学华西医院泌尿外科成都610044 河南科技大学第一附属医院泌尿外科河南洛阳471003 中南大学湘雅二医院泌尿外科长沙410011 开封市中心医院泌尿外科河南开封475001 南昌大学第一附属医院泌尿外科南昌330006 河南大学淮河医院泌尿外科河南开封475000 咸阳市中心医院泌尿外科陕西咸阳712000 西安交通大学第一附属医院泌尿外科西安710061 不详

膀胱癌是全球第十大最常被诊断出的癌症,在男性中更常见。经尿道膀胱肿瘤电切术既是膀胱肿瘤的重要诊断方法,也是非肌层浸润性膀胱癌的主要治疗手段。相较于传统单极电切,等离子双极电切具有手术效果好、并发症较少的优势,临床应用渐趋... 详细信息

膀胱癌是全球第十大最常被诊断出的癌症,在男性中更常见。经尿道膀胱肿瘤电切术既是膀胱肿瘤的重要诊断方法,也是非肌层浸润性膀胱癌的主要治疗手段。相较于传统单极电切,等离子双极电切具有手术效果好、并发症较少的优势,临床应用渐趋广泛。为规范常见病的诊疗,国家卫健委持续发布相关的临床路径,但临床路径的内容有限,对其进行释义可以更好的推广使用。本释义以最新发布的《膀胱肿瘤经尿道等离子电切术临床路径(2.19年版)》为蓝本,采用循证医学的方法,对路径中涉及的给药方案进行了详细解读,以期为医护及管理人员能够更好地理解、把握和正确运用临床路径提供参考。

关键词：临床路径膀胱肿瘤非肌层浸润性膀胱癌经尿道等离子电切术等离子双极电切术循证医学

良性前列腺增生经尿道前列腺等离子电切术临床路径释义

在线全文

学校读者我要写书评

暂无评论

医学新知 2022年第3期32卷 214-222页

作者：阎思宇黄兴陈征杨璐贾招辉彭谋任选义熊晶李晓东徐晓峰孙中义王永博李绪辉胡万里王婷靳英辉訾豪刘同族曾宪涛贺大林王行环中国研究型医院学会泌尿外科学专业委员会中国医疗保健国际交流促进会循证医学分会国家重点研发计划微创等离子手术体系研发和产业化项目组武汉大学中南医院循证与转化医学中心武汉430071 武汉大学中南医院泌尿外科武汉430071 暨南大学附属第一医院泌尿外科广州510630 四川大学华西医院泌尿外科成都610041 河南科技大学第一附属医院泌尿外科河南洛阳471003 中南大学湘雅二医院泌尿外科长沙410011 开封市中心医院泌尿外科河南开封475001 南昌大学第一附属医院泌尿外科南昌330006 河南大学淮河医院泌尿外科河南开封475000 咸阳市中心医院泌尿外科陕西咸阳712000 深圳大学总医院泌尿外科广东深圳518055 西安交通大学第一附属医院泌尿外科西安710061 不详

良性前列腺增生是引发中老年男性排尿功能障碍最为常见的一种良性疾病,也是导致下尿路症状的主要原因。经尿道前列腺等离子电切术效果好、安全可靠,已在临床中广泛应用。为进一步规范该手术的临床应用,国家卫生健康委员会于2.19年首次... 详细信息

良性前列腺增生是引发中老年男性排尿功能障碍最为常见的一种良性疾病,也是导致下尿路症状的主要原因。经尿道前列腺等离子电切术效果好、安全可靠,已在临床中广泛应用。为进一步规范该手术的临床应用,国家卫生健康委员会于2.19年首次发布了《良性前列腺增生经尿道前列腺等离子电切术临床路径》。鉴于临床路径的篇幅有限,本文以该路径为蓝本,遵照循证医学的思路与方法进行释义,旨在提供更为详尽的证据补充,以帮助医护人员和管理人员能更好地理解、把握和正确运用本临床路径。

关键词：临床路径良性前列腺增生下尿路症状经尿道等离子电切术等离子双极电切术循证医学